Mark Densel
Corporate Officer/Principal bij EFFECTOR THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Mark Densel
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Mark Densel via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Founder Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
USVP Management Co. LLC
 USVP Management Co. LLC Investment ManagersFinance USVP Management Co. LLC (US Venture Partners) is a venture capital firm founded in 1981 by Bill Bowes. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Tech/Sci/R&D Officer | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| APPLIED MOLECULAR TRANSPORT INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pomona College
 Pomona College Other Consumer ServicesConsumer Services Pomona College offers curriculum in the arts, humanities, social sciences and natural sciences. It was founded in 1887 and it is headquartered in Claremont, CA | College/University | Director/Board Member Undergraduate Degree | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Founder | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| US Air Force | Sovereign | Consultant / Advisor | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| U.S. Venture Partners X LP | Investment Managers | Private Equity Investor | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member | |
Accent Therapeutics, Inc.
 Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| Berkeley Law University of California | College/University | Corporate Officer/Principal | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Graduate Degree | |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| CALITHERA BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Investment Managers | Corporate Officer/Principal | |
| University of Massachusetts | College/University | Undergraduate Degree | |
| TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
River Vision Development Corp.
 River Vision Development Corp. BiotechnologyHealth Technology River Vision Development Corp. develops novel protein therapies. The firm provides therapy for the treatment of graves orbitopathy which is a condition in which an autoimmune response is mounted against tissues behind the eye, causing inflammation, tissue proliferation and excess production of extracellular matrix. The company was founded in 2011 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| University of California, Los Angeles | College/University | Doctorate Degree | |
St. Thomas Hospital, Inc.
 St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Innovative Genomics Institute | Founder | ||
Driver, Inc.
 Driver, Inc. Packaged SoftwareTechnology Services Driver, Inc. develops technology platform that connects cancer patients to treatments and knowledge. Its applications enables cancer patient to have an access treatment options. The company was founded by William R. Polkinghorn and Petros Giannikopoulos and is headquartered in San Francisco, CA. | Packaged Software | Director/Board Member | |
Mammoth Biosciences, Inc.
 Mammoth Biosciences, Inc. Internet Software/ServicesTechnology Services Mammoth Biosciences, Inc. operates CRISPR-based platform for disease detection. The firm offers its services under the categories of bioinformatics, biotechnology, genetics, health diagnostics and life science. The company was founded by Ashley Tehranchi, Janice Chen, Jennifer A. Doudna, Lucas Harrington and Trevor Martin and is headquartered in South San Francisco, CA. | Internet Software/Services | Founder | |
| The Royal Society | Investment Trusts/Mutual Funds | Corporate Officer/Principal |
Statistieken
Internationaal
| Verenigde Staten | 48 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 11 |
| Finance | 7 |
| Commercial Services | 3 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 108 |
| Corporate Officer/Principal | 61 |
| Independent Dir/Board Member | 35 |
| Director of Finance/CFO | 25 |
| Undergraduate Degree | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Jon Root | 28 |
| Larry Lasky | 27 |
| Christopher Ehrlich | 26 |
| Jennifer Doudna | 26 |
| Michael Hodges | 21 |
| John Smither | 20 |
| Brian Gallagher | 20 |
| Caroline Loewy | 17 |
| Alana McNulty | 12 |
| Stephen Worland | 12 |
| Barbara Klencke | 12 |
| Michael Byrnes | 10 |
| Elizabeth Bhatt | 9 |
| Mayank J. Gandhi | 8 |
| Premal Patel | 6 |
- Beurs
- Insiders
- Mark Densel
- Bedrijfsconnecties
